aod9604 dosage 50mg Peptide Who should not take AOD9604? Aod 9604 Injection - Liquid

Break periods between cycles Between AOD-9604 cycles, a break period allows receptor sensitivity to restore and prevents potential adaptation that could reduce effectiveness in future cycles

Each rabbit was observed individually in a controlled ground area for 20 minutes daily at a set time

Does not meaningfully raise IGF1 and shows a placebolike safety profile in human studies

Clean the injection site with an alcohol prep pad, pinch a fold of skin, insert the needle at a 45-90 degree angle (depending on body fat levels), inject slowly over 3-5 seconds, and dispose of used syringes immediately in a sharps container

However, development was discontinued in 2007 after the largest Phase IIb trial failed to demonstrate statistically significant weight loss compared to placebo